gptkbp:instance_of
|
gptkb:Corporation
|
gptkbp:acquisition
|
gptkb:Athenex,_Inc.
gptkb:Blue_Rock_Therapeutics
gptkb:Kymab_Ltd.
gptkb:Vividion_Therapeutics
gptkb:Ceres_Global_Ag_Corp.
gptkb:Monsanto_Company
gptkb:Nant_Kwest,_Inc.
gptkb:Asklepios_Bio_Pharmaceutical
gptkb:Dihon_Pharmaceutical_Group
gptkb:Kraton_Corporation
gptkb:Covestro_AG
gptkb:Ginkgo_Bioworks
gptkb:Schering_AG
gptkb:Conceptus,_Inc.
gptkb:Agra_Quest
Ask Bio.
Blue Rock.
Ceres.
Cropscience
Evofem Biosciences.
Evofem.
Ginkgo.
Kymab.
Nant Kwest.
Vividion.
|
gptkbp:agricultural_chemicals
|
fungicides
herbicides
insecticides
|
gptkbp:ceo
|
gptkb:Werner_Baumann
|
gptkbp:employees
|
approximately 100,000 (2020)
|
gptkbp:founded
|
1863
|
gptkbp:founder
|
gptkb:Friedrich_Bayer
|
gptkbp:global_presence
|
operations in over 80 countries
|
gptkbp:headquarters
|
gptkb:Leverkusen,_Germany
|
gptkbp:healthcare
|
Oncology drugs
Cardiovascular drugs
Women's health products
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bayer Group
|
gptkbp:industry
|
gptkb:pharmaceuticals
agricultural chemicals
|
gptkbp:invention
|
thousands of active patents
|
gptkbp:net_income
|
approximately €4 billion (2020)
|
gptkbp:operating_income
|
approximately €6 billion (2020)
|
gptkbp:partnerships
|
government agencies
non-profit organizations
various academic institutions
|
gptkbp:research_and_development
|
over €5 billion annually
|
gptkbp:revenue
|
approximately €43 billion (2020)
|
gptkbp:social_responsibility
|
environmental sustainability initiatives
community engagement programs
health and nutrition initiatives
|
gptkbp:stock_exchange
|
gptkb:Frankfurt_Stock_Exchange
|
gptkbp:stock_symbol
|
gptkb:BAYN
|
gptkbp:subsidiary
|
gptkb:Bayer_Crop_Science
gptkb:Bayer_Health_Care
|
gptkbp:sustainability_initiatives
|
Bayer's Sustainability Program
|
gptkbp:website
|
www.bayer.com
|
gptkbp:bfsParent
|
gptkb:Bayer_Crop_Science
|
gptkbp:bfsLayer
|
5
|